PMTC2013


Go to content

About PMTC2013

About PMTC2013



About PMTC2013
Conference Highlights
Program Topics
Who Should Attend?
Why Attend?



About PMTC2013
The 1st International Conference of Personalized Medicine and Targeted Therapies in Cancer will take place from the 31 January to 2 February, 2013 in Sharjah, UAE.

Organized by the Sharjah Research Academy, in collaboration with Sharjah University and the Institute Gustave-Roussy, the event will highlight and discuss hot topics of
targeted anti-cancer therapies being utilized and developed in the region and worldwide, and current updates on Personalized Medicine, addressing improvements in diagnosing diseases, increasing the safety of drugs and identifying future treatments to enhance patient care.

Conference Dates: 31 January - 2 February 2013
Organiser: Sharjah Research Academy
In collaboration with: University of Sharjah and Institute Gustave Roussy
Venue: Sharjah Medical Excellence Cluster

Conference Highlights

  • Comprehensive scientific program with a broad range of subspecialties and topic areas
  • Distinguished panel of leading experts from the field
  • Workshops and Courses
  • Abstract submission for oral and poster presentations


  • Program Topics

  • Tumor progression: basic and therapeutic aspects
  • Cancer biomarkers
  • Aberrant signaling pathways in malignancy
  • Novel targeted therapy in cancer
  • Chemotherapy resistance
  • Pharmacogenomics, personalized diagnostics and medicine
  • Genome project on drug development and cancer therapy
  • Epigenetics and its impact on cancer therapy


  • Who Should Attend?
    We warmly invite
    researchers from academia and industry, clinicians, oncologists, students, health managers, and health care personnel practicing oncology in all disciplines of oncology for their participation at this first conference in the Gulf region. We encourage them to contribute to this important exchange and to identify key advances in this field that is revolutionizing the medical world and holds the potential to greatly improve patient care. Stakeholders among government and decision makers are also invited.

    Why Attend?

    By attending PMTC2013, attendees will have the opportunity to:

  • Access some of the most respected and renowned medical professionals in the field of personalized medicine and targeted therapies in cancer
  • Network with a truly international audience, from several subspecialties
  • Free access to the exhibition running alongside the conference, and gain insight to the latest product information and trends
  • Enhance medical knowledge and practice through the rich resources available


  • Back to content | Back to main menu